Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Ipilimumab + Pembrolizumab for Brain Metastasis from Melanoma
Recruiting1 awardPhase 2
Houston, Texas
This trial is testing ipilimumab and pembrolizumab to treat melanoma that has spread to the brain. These drugs may help the body's immune system attack the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.